Maslennikov R, Ivashkin V, Efremova I, Shirokova E. Immune disorders and rheumatologic manifestations of viral hepatitis. World J Gastroenterol 2021; 27(18): 2073-2089 [PMID: 34025065 DOI: 10.3748/wjg.v27.i18.2073]
Corresponding Author of This Article
Roman Maslennikov, MD, PhD, Assistant Professor, Professor, Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Pogodinskaya Street, 1, bld. 1, Moscow 119435, Russia. mmmm00@yandex.ru
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Shoulders, elbows, hips, knees, ankles, left second and third metacarpophalangeal
Ankles and knees followed by the wrists and fingers
Duration of arthritis
No data
3 mo
Rash
Maculopapular, non-itchy rash all over her body
No
Fever
No
No
Jaundice
No
No
Pruritus
No
No
Other symptoms and signs
Retroorbital pain, eye discharge, headache, and loss of appetite
No
Rheumatoid factor
No
No
Antinuclear antibodies
No
No
White blood cells, 109/L
Normal
2.8
Erythrocyte sedimentation rate, mm/h
35
24
C-reactive protein, mg/L
25
3
Transaminases
↑
↑
Complement
C3 - ↑; C4 -Normal
No data
Treatment
No data
No specific treatment
Table 5 A summary of the main immunological and rheumatologic manifestation in viral hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis E
Rheumatoid factor
Only 2 cases
Approximately 12% of patients
15% of patients
1 case in a patient without transplant
Antinuclear antibodies
In a case of lupus-like reaction and some cases of AIH triggered by HAV infection
Approximately 25% of patients
20%-30% of patients
9%-37% (acute) and 24% (chronic) of patients
Cryoglobulins
95% of patients in 1 study
2% of patients
65% of patients
7% (acute) and 27% (chronic) of patients
Arthralgia
10%-20% of patients
3% of patients
42% of patients
Approximately 60% of patients
Arthritis
Only in patients with vasculitis (7 cases)
About a quarter of patients with pain in joints
5%-10% of patients
2 cases
GN
4 cases of mesangio-proliferative GN
3% of GN: membranous GN (40%); membrano-proliferative GN (20%); focal segmental glomerulo-sclerosis (20%); mesangio-proliferative GN (10%), others (10%)
Approximately 50% of GN: membranous GN (5%); membrano-proliferative GN (55%); focal segmental glomerulo-sclerosis (25%); mesangio-proliferative GN (20%), others (5%)
1 case of membrano-proliferative GN; some cases of GN after transplantation
Henoch-Schonlein purpura
7 cases
Some cases
Some cases
1 case
CGV
4 cases
10% of non-HCV CGV cases
90%-95% of CGV cases
Some cases
PAN
No cases
35% of PAN cases
20% of PAN cases
No cases
Uveitis
Some cases
2% of patients
Some cases
No cases
AIH
11 cases
55% of AIH cases
Very rare
No cases
PBC
1 case of overlap syndrome
40% of PBC cases
Approximately 10% of PBC cases
No cases
Citation: Maslennikov R, Ivashkin V, Efremova I, Shirokova E. Immune disorders and rheumatologic manifestations of viral hepatitis. World J Gastroenterol 2021; 27(18): 2073-2089